Davis Blaine 4
4 · Protara Therapeutics, Inc. · Filed Jan 21, 2021
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-19+75,000→ 75,000 totalExercise: $19.82Exp: 2031-01-18→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest on the one year anniversary of January 19, 2021 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.